MiRNA21

No

%

No

%

p

Down expressed N = 19

Up expressed N = 26

Pathology

Low risk pathology

12

(41)

17

(59

0.878

High risk pathology

7

(43)

9

(56)

Differentiation of tumor

Well differentiated

4

(57)

3

(43)

0.609

Moderate differentiated

8

(36)

14

(64)

Poorly differentiated

7

(44)

9

(56)

Lymphovascular invasion

Negative

11

(73)

4

(27)

0.01

Positive

6

(32)

13

(68)

Not assessed

2

(18)

9

(82)

T

Limited invasion

4

(57)

3

(43)

0.433

Marked invasion

15

(39)

23

(61)

N

N0

11

(84)

2

(15)

0.002

N+

8

(25 )

24

(75)

M

M0

13

(59)

9

(41)

0.01

Metastatic

6

(26)

17

(74)

Stage

Early stage

10

(83)

2

(17)

0.001

Advanced stage

9

(27)

24

(73)